The Joint Corp Reiterates All Elements Of Its FY24 Guidance; Expects System-Wide Sales To Be $530M - $545M
Portfolio Pulse from Benzinga Newsdesk
The Joint Corp has reiterated its FY24 guidance, expecting system-wide sales to be between $530M and $545M. System-wide comp sales for clinics open 13 months or more are projected to be in the mid-single digits. The company plans to open 60 to 75 new franchised clinics in 2024, down from 104 in 2023.
August 08, 2024 | 10:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The Joint Corp has reiterated its FY24 guidance, expecting system-wide sales to be between $530M and $545M. System-wide comp sales for clinics open 13 months or more are projected to be in the mid-single digits. The company plans to open 60 to 75 new franchised clinics in 2024, down from 104 in 2023.
The reiteration of FY24 guidance provides stability and predictability for investors. However, the reduction in new franchised clinic openings compared to 2023 may be seen as a potential slowdown in growth, balancing the overall impact to neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100